Hydrogen-rich water alleviates cyclosporine A-induced nephrotoxicity via the Keap1/Nrf2 signaling pathway. 2020

Yi Lu, and Chun-Fang Li, and Na-Na Ping, and Yu-Yao Sun, and Zheng Wang, and Gong-Xiao Zhao, and Shi-Hui Yuan, and Abdoulaye Issotina Zibrila, and Lynn Soong, and Jin-Jun Liu
Key Laboratory of Shannxi Province for Craniofacial Precision Medicine Research, College of Stomatology, Xi'an Jiaotong University, Xi'an, Shaanxi, China.

Oxidative stress induced by long-term cyclosporine A (CsA) administration is a major cause of chronic nephrotoxicity, which is characterized by tubular atrophy, tubular cell apoptosis, and interstitial fibrosis in the progression of organ transplantation. Although hydrogen-rich water (HRW) has been used to prevent various oxidative stress-related diseases, its underlying mechanisms remain unclear. This study investigated the effects of HRW on CsA-induced nephrotoxicity and its potential mechanisms. After administration of CsA (25 mg/kg/day), rats were treated with or without HRW (12 mL/kg) for 4 weeks. Renal function and vascular activity were investigated. Histological changes in kidney tissues were analyzed using Masson's trichrome and terminal deoxynucleotidyl transferase dUTP nick-end labeling stains. Oxidative stress markers and the activation of the Kelch-like ECH-associated protein 1 (Keap1)/nuclear factor erythroid 2-related factor 2 (Nrf2) signaling pathway were also measured. We found that CsA increased the levels of reactive oxygen species (ROS) and malonaldehyde (MDA), but it reduced glutathione (GSH) and superoxide dismutase (SOD) levels. Such alterations induced vascular dysfunction, tubular atrophy, interstitial fibrosis, and tubular apoptosis. This was evident secondary to an increase in urinary protein, serum creatinine, and blood urea nitrogen, ultimately leading to renal dysfunction. Conversely, HRW decreased levels of ROS and MDA while increasing the activity of GSH and SOD. This was accompanied by an improvement in vascular and renal function. Moreover, HRW significantly decreased the level of Keap1 and increased the expression of Nrf2, NADPH dehydrogenase quinone 1, and heme oxygenase 1. In conclusion, HRW restored the balance of redox status, suppressed oxidative stress damage, and improved kidney function induced by CsA via activation of the Keap1/Nrf2 signaling pathway.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008297 Male Males
D001806 Blood Urea Nitrogen The urea concentration of the blood stated in terms of nitrogen content. Serum (plasma) urea nitrogen is approximately 12% higher than blood urea nitrogen concentration because of the greater protein content of red blood cells. Increases in blood or serum urea nitrogen are referred to as azotemia and may have prerenal, renal, or postrenal causes. (From Saunders Dictionary & Encyclopedia of Laboratory Medicine and Technology, 1984) BUN,Nitrogen, Blood Urea,Urea Nitrogen, Blood
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D006859 Hydrogen The first chemical element in the periodic table with atomic symbol H, and atomic number 1. Protium (atomic weight 1) is by far the most common hydrogen isotope. Hydrogen also exists as the stable isotope DEUTERIUM (atomic weight 2) and the radioactive isotope TRITIUM (atomic weight 3). Hydrogen forms into a diatomic molecule at room temperature and appears as a highly flammable colorless and odorless gas. Protium,Hydrogen-1
D000072019 Kelch-Like ECH-Associated Protein 1 An adaptor protein characterized by an N-terminal BTB-POZ DOMAIN and six KELCH REPEATS that functions as a substrate for the E3 UBIQUITIN LIGASE complex. It negatively-regulates NF-E2-RELATED FACTOR 2 by targeting it for ubiquitination and degradation by the PROTEASOME. It also represses genes regulated by ANTIOXIDANT RESPONSE ELEMENTS. KEAP-1 Protein,KEAP1 Protein,KEAP 1 Protein,Kelch Like ECH Associated Protein 1
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013482 Superoxide Dismutase An oxidoreductase that catalyzes the reaction between SUPEROXIDES and hydrogen to yield molecular oxygen and hydrogen peroxide. The enzyme protects the cell against dangerous levels of superoxide. Hemocuprein,Ag-Zn Superoxide Dismutase,Cobalt Superoxide Dismutase,Cu-Superoxide Dismutase,Erythrocuprein,Fe-Superoxide Dismutase,Fe-Zn Superoxide Dismutase,Iron Superoxide Dismutase,Manganese Superoxide Dismutase,Mn-SOD,Mn-Superoxide Dismutase,Ag Zn Superoxide Dismutase,Cu Superoxide Dismutase,Dismutase, Ag-Zn Superoxide,Dismutase, Cobalt Superoxide,Dismutase, Cu-Superoxide,Dismutase, Fe-Superoxide,Dismutase, Fe-Zn Superoxide,Dismutase, Iron Superoxide,Dismutase, Manganese Superoxide,Dismutase, Mn-Superoxide,Dismutase, Superoxide,Fe Superoxide Dismutase,Fe Zn Superoxide Dismutase,Mn SOD,Mn Superoxide Dismutase,Superoxide Dismutase, Ag-Zn,Superoxide Dismutase, Cobalt,Superoxide Dismutase, Fe-Zn,Superoxide Dismutase, Iron,Superoxide Dismutase, Manganese
D014867 Water A clear, odorless, tasteless liquid that is essential for most animal and plant life and is an excellent solvent for many substances. The chemical formula is hydrogen oxide (H2O). (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Hydrogen Oxide
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal

Related Publications

Yi Lu, and Chun-Fang Li, and Na-Na Ping, and Yu-Yao Sun, and Zheng Wang, and Gong-Xiao Zhao, and Shi-Hui Yuan, and Abdoulaye Issotina Zibrila, and Lynn Soong, and Jin-Jun Liu
January 2020, Frontiers in pharmacology,
Yi Lu, and Chun-Fang Li, and Na-Na Ping, and Yu-Yao Sun, and Zheng Wang, and Gong-Xiao Zhao, and Shi-Hui Yuan, and Abdoulaye Issotina Zibrila, and Lynn Soong, and Jin-Jun Liu
August 2021, Toxins,
Yi Lu, and Chun-Fang Li, and Na-Na Ping, and Yu-Yao Sun, and Zheng Wang, and Gong-Xiao Zhao, and Shi-Hui Yuan, and Abdoulaye Issotina Zibrila, and Lynn Soong, and Jin-Jun Liu
May 2021, Antioxidants (Basel, Switzerland),
Yi Lu, and Chun-Fang Li, and Na-Na Ping, and Yu-Yao Sun, and Zheng Wang, and Gong-Xiao Zhao, and Shi-Hui Yuan, and Abdoulaye Issotina Zibrila, and Lynn Soong, and Jin-Jun Liu
July 2020, BioFactors (Oxford, England),
Yi Lu, and Chun-Fang Li, and Na-Na Ping, and Yu-Yao Sun, and Zheng Wang, and Gong-Xiao Zhao, and Shi-Hui Yuan, and Abdoulaye Issotina Zibrila, and Lynn Soong, and Jin-Jun Liu
December 2022, European journal of pharmacology,
Yi Lu, and Chun-Fang Li, and Na-Na Ping, and Yu-Yao Sun, and Zheng Wang, and Gong-Xiao Zhao, and Shi-Hui Yuan, and Abdoulaye Issotina Zibrila, and Lynn Soong, and Jin-Jun Liu
January 2023, Frontiers in pharmacology,
Yi Lu, and Chun-Fang Li, and Na-Na Ping, and Yu-Yao Sun, and Zheng Wang, and Gong-Xiao Zhao, and Shi-Hui Yuan, and Abdoulaye Issotina Zibrila, and Lynn Soong, and Jin-Jun Liu
March 2020, Experimental and therapeutic medicine,
Yi Lu, and Chun-Fang Li, and Na-Na Ping, and Yu-Yao Sun, and Zheng Wang, and Gong-Xiao Zhao, and Shi-Hui Yuan, and Abdoulaye Issotina Zibrila, and Lynn Soong, and Jin-Jun Liu
September 2023, Nature communications,
Yi Lu, and Chun-Fang Li, and Na-Na Ping, and Yu-Yao Sun, and Zheng Wang, and Gong-Xiao Zhao, and Shi-Hui Yuan, and Abdoulaye Issotina Zibrila, and Lynn Soong, and Jin-Jun Liu
January 2024, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Yi Lu, and Chun-Fang Li, and Na-Na Ping, and Yu-Yao Sun, and Zheng Wang, and Gong-Xiao Zhao, and Shi-Hui Yuan, and Abdoulaye Issotina Zibrila, and Lynn Soong, and Jin-Jun Liu
October 2023, Journal of ethnopharmacology,
Copied contents to your clipboard!